PROM1 and metastatic melanoma: We show for the first time the necessity of iterative sorting to isolate pure marker-positive and marker-negative populations for comparative studies of marker-positive cells in tumours, and present evidence that despite CD133+ and CD133- cells being equally tumourigenic, CD133 defines two phenotypically distinct populations in metastatic melanoma.